Vimta Labs Limited (NSE:VIMTALABS)
401.70
-6.50 (-1.59%)
Apr 2, 2026, 11:50 AM IST
Vimta Labs Revenue
Vimta Labs had revenue of 986.33M INR in the quarter ending December 31, 2025, with 9.69% growth. This brings the company's revenue in the last twelve months to 3.94B, up 11.59% year-over-year. In the fiscal year ending March 31, 2025, Vimta Labs had annual revenue of 3.45B with 19.25% growth.
Revenue (ttm)
3.94B
Revenue Growth
+11.59%
P/S Ratio
4.61
Revenue / Employee
3.00M
Employees
1,315
Market Cap
18.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.45B | 557.57M | 19.25% |
| Mar 31, 2024 | 2.90B | -294.23M | -9.22% |
| Mar 31, 2023 | 3.19B | 402.99M | 14.46% |
| Mar 31, 2022 | 2.79B | 677.23M | 32.09% |
| Mar 31, 2021 | 2.11B | 298.68M | 16.49% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Cipla | 279.67B |
| Apollo Hospitals Enterprise | 242.15B |
| Divi's Laboratories | 103.14B |
| Dishman Carbogen Amcis | 27.97B |
| Indoco Remedies | 17.60B |
| Solara Active Pharma Sciences | 12.55B |
| Shalby | 11.19B |
Vimta Labs News
- 2 months ago - Vimta Labs Ltd (BOM:524394) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amid ... - GuruFocus
- 2 months ago - Q3 2026 Vimta Labs Ltd Earnings Call Transcript - GuruFocus
- 5 months ago - Vimta Labs Ltd (BOM:524394) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic ... - GuruFocus
- 5 months ago - Q2 2026 Vimta Labs Ltd Earnings Call Transcript - GuruFocus
- 7 months ago - Vimta Labs shares hit fresh all-time high, surges 7% - Business Upturn
- 7 months ago - Vimta Labs shares surge 7%, hit fresh 52-week high amid heavy trading volumes - Business Upturn
- 1 year ago - Stocks to watch on April 29: Wipro, UCO Bank, Central Bank of India, Go Digit, Avenue Supermarts, Oberoi Realty, Ultratech, Vimta Labs, RBL Bank - Business Upturn
- 1 year ago - Vimta Labs Q4 FY25 profit rises 31% YoY; announces 1:1 bonus issue and new biologics R&D foray - Business Upturn